Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points

Completed · Phase 2

Conditions studied: Myofascial Pain Syndromes

In brief

The purpose of this pilot study is to explore the potential usefulness of a heated lidocaine 70 mg and tetracaine 70 mg topical patch for the treatment of pain associated with myofascial trigger points.

Key facts

Study ID

NCT01106989

Run by

ZARS Pharma Inc.

People needed

20

Starts

2010-06-01

Expected to finish

2011-01-01

Last updated by the study team

2012-03-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• be at least 18 years of age
• have a clinical diagnosis of pain (minimum 1-month duration) associated with up to 3 myofascial trigger points
• have trigger points confined to the upper back, shoulder, and neck

You may not qualify if…

• have used any topically applied pain medication on the target treatment area within 3 days preceding the Screening/Baseline Visit
• have used any topically applied pain medication on the target treatment area within 3 days preceding the Screening/Baseline Visit
• have used any injected pain medication with 28 days preceding the Screening/Baseline Visit
• are receiving class 1 antiarrhythmic drugs (ie, tocainide, mexiletine, etc.)
• Other protocol-defined inclusion/exclusion criteria may apply.

Where it is running

• The Center for Clinical Research — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.